LungBlog

A Quebec commission has ruled that 10 former Alcan employees developed cancer as a result of their work in smelters and as such their families deserve to be compensated.

Desiree Collins, who claimed in a lawsuit that FEMA trailers exposed the residents to formaldehyde, has died of lung cancer at the age of 47. Collins died on July 2. Her lung cancer was diagnosed a week before she died.

Non–small cell lung cancer with pulmonary metastasis in the primary lobe (PM+) is classified as pathologic stage IIIB. Although stage IIIB PM+ indicates a poor prognosis, this stage includes various subgroups with heterogeneous clinical outcomes. The objective of this study was to extract a subgroup of patients with stage IIIB PM+ non–small cell lung cancer with a better prognosis and assess their biological characteristics and metastatic mechanisms.

 Lung cancer is the second most common type of adult cancer in the U.S. and the leading cause of cancer death. This year, the American Cancer Society estimates 213,380 new cases will be diagnosed and 160,390 men and women will die from the disease.

A new technique for treatment of lung cancer when conventional methods are not possible has come to Blount County by way of England.

People diagnosed with the number one cancer killer, lung cancer, now have a new resource for information from the National Lung Cancer Partnership.This month, the group debuted Living With a Diagnosis of Lung Cancer, a free booklet dedicated to answering basic questions about what the diagnosis means .

. . . there’s likely a neighborhood hit by lung cancer. South Boston leads the pack, but it’s fighting back.

Dogs can detect lung and breast cancers more effectively than state-of-the-art screening equipment, scientists say.

The families of 10 former Alcan employees who contracted lung cancer while working in the company’s aluminum smelters are eligible for thousands of dollars in compensation, a Quebec workplace accident commission ruled Friday.

A course of chemotherapy prior to standard treatment, known as “induction” chemotherapy, appears to improve survival in patients with advanced non-small-cell lung cancer (NSCLC), the most common type of lung cancer, according to a report in the International Journal of Radiation Oncology*Biology*Physics.